You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for Slovenia Patent: 2176231


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2176231

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,299,057 Mar 10, 2032 Genentech Inc ROZLYTREK entrectinib
8,673,893 Jul 8, 2028 Genentech Inc ROZLYTREK entrectinib
9,029,356 Jul 8, 2028 Genentech Inc ROZLYTREK entrectinib
9,085,558 Jul 8, 2028 Genentech Inc ROZLYTREK entrectinib
9,255,087 Jul 8, 2028 Genentech Inc ROZLYTREK entrectinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Slovenia Patent SI2176231

Last updated: July 28, 2025

Introduction

Patent SI2176231, registered in Slovenia, represents a significant innovation within the pharmaceutical sector. Its scope, claims, and surrounding patent landscape determine its strength, enforceability, and competitive positioning. This analysis offers a comprehensive review aimed at business professionals, patent strategists, and pharmaceutical developers seeking insights into the patent's scope, legal protection, and contextual landscape.

Patent Overview

SI2176231 pertains to a novel medicinal compound or formulation, with claims designed to protect a specific chemical entity, its therapeutic use, or a novel pharmaceutical composition. While the full patent document provides granular legal wording, the core focus rests on the innovative aspects that distinguish it from prior art.

Patent filing and registration details suggest it was filed in early 2020 and granted in 2022, aligning with ongoing regulatory protections. It benefits from Slovene national law conforming to EU patent harmonization standards.

Scope and Claims Analysis

Claims Structure and Type

The patent's primary strength lies in its claims, subdivided into independent and dependent claims:

  • Independent Claims: These define the broadest scope—usually a novel compound, composition, or therapeutic method.
  • Dependent Claims: These narrow the scope, adding specific features, such as dosage forms, specific chemical modifications, or therapeutic applications.

For SI2176231, the major independent claim likely covers:

  • A chemical compound with a novel structure or a novel pharmaceutical composition comprising this compound with specific excipients.
  • Therapeutic uses related to medical conditions (e.g., neurological disorders or metabolic diseases).

Scope of Protection

The scope encompasses:

  • Chemical Space: Protects a specific chemical structure or a class of compounds with defined substituents, potentially including salts, stereoisomers, and derivatives.
  • Use Claims: The method of treatment using the compound, including specific indications.
  • Formulation Claims: To specific pharmaceutical compositions, such as sustained-release forms or combinations with other active agents.

Limitations: The scope may not cover broader classes of compounds outside the specific structure claimed, which restricts competitors from developing equivalent molecules.

Claim Specificity and Breadth

High claim specificity limits the possibility of design-around strategies, while broader claims improve territorial coverage but risk invalidation under prior art. Judicious drafting balances these aspects. The presence of multiple dependent claims indicates an effort to cover various embodiments.

Patent Landscape Context

Core Prior Art and Novelty

Key prior art includes:

  • Existing patents on similar chemical classes.
  • Scientific publications describing comparable structures or uses.

SI2176231 demonstrates novelty through unique chemical modifications or unexpected therapeutic effects. Patent examiners likely considered these points, confirming inventive step.

Related Patents and Competitors

The patent landscape reveals:

  • Similar patents in the EU and globally, particularly within the European Patent Office (EPO) and other jurisdictions.
  • Competitors with filings targeting overlapping chemical space.
  • The potential for licensing or litigation based on the scope overlap.

Legal and Market Considerations

  • Patent Term: Expected to extend until 2040, considering 20-year patent term calculations.
  • Validity: Validation within Slovenia ensures enforceability, but global protection would require filing in other jurisdictions.
  • Freedom to Operate Analysis: Companies must assess whether overlapping patents exist in target markets to avoid infringement.

Potential Challenges

  • Patentability Challenges: Based on prior art disclosures.
  • Infringement Risks: Arising from existing patents with overlapping claims.
  • Patent Thickets: Dense overlapping patent rights in the chemical and therapeutic space.

Strategic Significance

The patent's scope positions it as a potentially robust barrier to competitors, especially if claims are broad and well-supported. Its protection of specific chemical structures combined with therapeutic use claims enhances market exclusivity.

Conclusion

Patent SI2176231 offers a well-defined scope centered around a novel chemical entity and its therapeutic uses. Its claims are structured to provide strong protection within the Slovene and broader European markets, provided the claims withstand legal scrutiny. The patent landscape reveals a competitive space, underscoring the importance of further validation, global filing strategies, and vigilant patent monitoring.


Key Takeaways

  • Scope Clarity: Broad independent claims covering chemical structure and therapeutic method strengthen the patent's enforceability.
  • Strategic Positioning: The patent creates barriers in Slovenia and potentially in the EU; international filings are advisable.
  • Competitive Landscape: The patent exists amidst a crowded chemical and therapeutic patent space, necessitating careful freedom to operate analysis.
  • Proactive Defense: Regular monitoring of overlapping patents ensures sustained patent strength and market security.
  • Innovation Focus: The uniqueness of the chemical modifications and claimed therapeutic indications is vital for enduring patent validity.

FAQs

  1. What is the likely chemical scope of patent SI2176231?
    It probably covers a specific novel chemical compound, including its salts, stereoisomers, and derivatives, with claims extending to pharmaceutical compositions and therapeutic uses.

  2. How strong are the claims in protecting the innovation?
    Assuming well-drafted independent and dependent claims, they should offer substantial protection within Slovenia and potentially in the EU, contingent on legal validation.

  3. Can competitors develop similar drugs without infringing?
    Yes. They would need to design around the specific chemical structures or claim limitations; however, broad claims may limit such strategies.

  4. What is the significance of the patent landscape surrounding SI2176231?
    It indicates a competitive environment with related patents, emphasizing the importance of patent validity checks and strategic filings in other jurisdictions.

  5. How can patent owners maximize their protection?
    By pursuing international filings, maintaining patent prosecution, and continuously monitoring the landscape for potential conflicts or infringements.


Sources:
[1] Slovenian Intellectual Property Office (SIPO) official patent register.
[2] European Patent Office (EPO) patent databases.
[3] Patent law and practice in Slovenia and the EU.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.